This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why did Community Health Stock Sink More Than 50% in a Year?
by Zacks Equity Research
Community Health (CYH) underperforms the industry due to rising expenses, ailing revenues and a weak guidance.
5 Growth Stocks in MedTech Set to Scale Higher in 2018
by Zacks Equity Research
The U.S. MedTech markets have been riding high with merger and acquisitions in focus.
Zacks.com featured highlights include: Louisiana-Pacific, ManpowerGroup, Kulicke and Soffa, Universal Health and DMC
by Zacks Equity Research
Zacks.com featured highlights include: Louisiana-Pacific, ManpowerGroup, Kulicke and Soffa, Universal Health and DMC
Tenet Healthcare Sells MacNeal Hospital to Streamline Trade
by Zacks Equity Research
Tenet Healthcare's (THC) divestitures aim at debt repayment, reduction of interest burden and streamlining of core business.
5 Low-Leverage Stocks to Buy as Fed Targets 4 Rate Hikes in 2018
by Zacks Equity Research
With the Federal Reserve targeting four interest rates hikes this year, the market scenario does not seem to be much in favor of companies opting for debt financing.
Why Earnings Season Could Be Great for Universal Health (UHS)
by Zacks Equity Research
Universal Health (UHS) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
Can Segmental Strength Drive Integra's (IART) Q4 Earnings?
by Zacks Equity Research
Integra LifeSciences (IART) well poised to gain from strength in Orthopedics and Tissue Technologies in Q4.
Will Lower Volume Hurt Tenet Healthcare's (THC) Q4 Earnings?
by Zacks Equity Research
Industry-wide softness in admissions might affect Tenet Healthcare's (THC) fourth-quarter results.
Can PBM Unit Drive Express Scripts' (ESRX) Earnings in Q4?
by Zacks Equity Research
Express Scripts (ESRX) expects Q4 results to show earnings growth on strength in PBM segment.
HCA Healthcare's Top Line Grows on Buyouts, Bad Debts Hurt
by Zacks Equity Research
Although HCA Healthcare's (HCA) top line continues to grow on the back of admissions, industry wide softness in volume, political uncertainty and high bad debt bother.
Can Tenet Healthcare (THC) Get Back on Growth Path in 2018?
by Zacks Equity Research
Shares of Tenet Healthcare (THC) have lost significantly last year owing to lower revenues, weak margins, high bad debts and expenses.
Will Community Health Bounce Back in 2018 After a Dismal 2017?
by Zacks Equity Research
Community Health (CYH) suffered in 2017 from weak volumes and high costs. Let's see how this year unfolds.
Acadia Healthcare: 2017 Was No Good, Will 2018 be Better?
by Zacks Equity Research
Acadia Healthcare (ACHC) suffers due to weak U.K. business. Let's see how this year unfolds
Universal Health Grows Inorganically, Rising Costs a Drag
by Zacks Equity Research
Universal Health's (UHS) top line grows on solid Acute Care and Behavioral Health platforms. Nevertheless, surging level of debt bothers.
Universal Health Services (UHS) Hits 52-Week Low on Dull Q3
by Zacks Equity Research
Universal Health (UHS) stock suffers on soft third-quarter results and a tepid outlook.
Lower Admissions to Hurt Tenet Healthcare (THC) Q3 Earnings?
by Zacks Equity Research
Tenet Healthcare's (THC) third-quarter earnings are likely to be affected by lower revenues and higher expenses
Can Admissions Rise Fuel Universal Health (UHS) Q3 Earnings?
by Zacks Equity Research
Universal Health's (UHS) third-quarter results are likely to be driven by solid revenue growth in both its Acute Care and Behavioral Health segments.
Tenet Healthcare Sells Hospital Unit to Streamline Business
by Zacks Equity Research
Tenet Healthcare (THC) sells its hospital unit to focus on core growth areas.
Mednax Suffers From Low Patient Admissions, High Expenses
by Zacks Equity Research
The stock of Mednax (MD) is possibly suffering from decline in business volumes along with cost inflation.
HCA Healthcare Rides on Acquisitions, Weak Volumes Bother
by Zacks Equity Research
A number of acquisitions have added facilities and widened network at HCA Healthcare (HCA). Weak admissions, however, continue to bother.
Universal Health (UHS) Grows on Buyouts, Expenses a Drag
by Zacks Equity Research
Despite solid revenue growth backed by inorganic strategies, Universal Health's (UHS) rising level of debt and expenses continue to weigh on margins.
Acadia Healthcare (ACHC) Up 42% This Year: Is Upside Left?
by Zacks Equity Research
A mix of factors ranging from industry to company specific favor the stock of Acadia Healthcare (ACHC), helping it to drive solid returns.
Tenet Healthcare (THC) Shuffles Top Brass: What to Expect?
by Zacks Equity Research
Tenet Healthcare (THC) is searching for a new CEO and redoing its board at a time when the company's operations are facing troubles.
Why Is Universal Health (UHS) Down 14.3% Since the Last Earnings Report?
by Zacks Equity Research
Universal Health (UHS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Universal Health (UHS) Q2 Earnings & Revenues Lag Estimates
by Zacks Equity Research
Universal Health's (UHS) lagged second-quarter earnings primarily due to lower revenues and higher expenses.